A soluble form of CTLA-4 is present in paediatric patients with acute lymphoblastic leukaemia and correlates with CD1d+ expression.
CTLA-4 is a key factor in regulating and maintaining self tolerance, providing a negative signal to the T cell and thus limiting immune responses. Several polymorphisms within the CTLA-4 gene have been associated with an increased risk of developing autoimmune diseases and, very recently, with susce...
Guardado en:
Autores principales: | Rita Simone, Claudya Tenca, Franco Fais, Matteo Luciani, Giulio De Rossi, Giampaola Pesce, Marcello Bagnasco, Daniele Saverino |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c72fbfdb2a4141708d5861e28637b799 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum CTLA-4 and IL-10.
por: Anna Maria Riccio, et al.
Publicado: (2012) -
Total Body Irradiation in Haematopoietic Stem Cell Transplantation for Paediatric Acute Lymphoblastic Leukaemia: Review of the Literature and Future Directions
por: Bianca A. W. Hoeben, et al.
Publicado: (2021) -
Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia
por: Henrik Lilljebjörn, et al.
Publicado: (2016) -
Osteonecrosis as the presenting feature in a child with acute lymphoblastic leukaemia
por: Lim Sern Chin, et al.
Publicado: (2021) -
Cancer drivers and clonal dynamics in acute lymphoblastic leukaemia subtypes
por: James B. Studd, et al.
Publicado: (2021)